In contrast, expression of CD44 (and ALDH1, a phosphorylated signal transducer and activator of transcription 3 known as p-STAT3) was reported to be associated with a poor prognosis for HNSCC patients [48]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.